Engineering Organs: The Science Powering Xenotransplantation

In this episode of Moving Medicine Forward, Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation and why it may represent a true turning point in medicine.From CRISPR-driven genetic engineering to breakthroughs in immunosuppression and scalable organ production, Dr. Fisher breaks down how decades of research are converging to make cross-species organ transplants a clinical reality.The conversation also dives into what this means for patients, how it could transform transplant access, and the critical role of rigorous, collaborative clinical research in translating breakthrough science into real-world care.01:23 Dr. Fisher’s path into transplant surgery03:05 Why xenotransplantation is reaching a turning point (CRISPR + immunosuppression)04:47 Advances enabling scalability, safety, and compatibility 08:32 Ethics, risks, and clearing misconceptions10:27 Real-world patient impact and clinical considerations 13:10 Logistics, coordination, and clinical execution15:49 New immunosuppression strategies driving success17:44 Collaboration, ethics, and managing risk 20:49 Eliminating waitlists: expanding access to transplant22:54 Milestones toward adoption and future outlook